| MeSH term | MeSH ID | Detail |
|---|---|---|
| Adenocarcinoma | D000230 | 166 associated lipids |
| Colonic Neoplasms | D003110 | 161 associated lipids |
| Cell Transformation, Neoplastic | D002471 | 126 associated lipids |
| Thrombosis | D013927 | 49 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
| Colorectal Neoplasms | D015179 | 10 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| Familial Mediterranean Fever | D010505 | 12 associated lipids |
| Zellweger Syndrome | D015211 | 39 associated lipids |
| Adenomatous Polyposis Coli | D011125 | 16 associated lipids |
29623-28-7
29623-28-7 is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 1002 references associated with 29623-28-7 in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 29623-28-7
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 29623-28-7
PubChem Associated disorders and diseases
PubChem Biomolecular Interactions and Pathways
NCBI Entrez Crosslinks
All references with 29623-28-7
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| pmid: | ||||
| Pongracz J and Lord JM | The lipoxygenase product 13-hydroxyoctadecadienoic acid (13-HODE) is a selective inhibitor of classical PKC isoenzymes. | 1999 | Biochem. Biophys. Res. Commun. | pmid:10079174 |
| Fang X et al. | 13-(S)-hydroxyoctadecadienoic acid (13-HODE) incorporation and conversion to novel products by endothelial cells. | 1999 | J. Lipid Res. | pmid:10191294 |
| Friedrichs B et al. | 13-HPODE and 13-HODE modulate cytokine-induced expression of endothelial cell adhesion molecules differently. | 1999 | Biofactors | pmid:10221158 |
| Truitt A et al. | Antiplatelet effects of conjugated linoleic acid isomers. | 1999 | Biochim. Biophys. Acta | pmid:10320806 |
| Sauer LA et al. | 13-Hydroxyoctadecadienoic acid is the mitogenic signal for linoleic acid-dependent growth in rat hepatoma 7288CTC in vivo. | 1999 | Cancer Res. | pmid:10493526 |
| Blask DE et al. | Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events. | 1999 | Cancer Res. | pmid:10493527 |
| Sakashita T et al. | Essential involvement of 12-lipoxygenase in regiospecific andstereospecific oxidation of low density lipoprotein by macrophages. | 1999 | Eur. J. Biochem. | pmid:10504415 |
| Chen NG et al. | PPARgamma agonists enhance human vascular endothelial adhesiveness by increasing ICAM-1 expression. | 1999 | Biochem. Biophys. Res. Commun. | pmid:10512746 |
| Blackburn ML et al. | Specific protein targets of 13-oxooctadecadienoic acid (13-OXO) and export of the 13-OXO-glutathione conjugate in HT-29 cells. | 1999 | Biochim. Biophys. Acta | pmid:10521706 |